Pleasanton, CA - March 12, 2006 - LISA Laser USA, Inc. announced that it has entered into an agreement with HealthTronics Inc. of Austin Texas to be the exclusive distributor of the Revolix product line in the USA urological market.

“We are very pleased to be entering into this agreement with HealthTronics and look forward to a very successful relationship,” said Peter Allen, President and CEO of LISA laser USA, Inc.

About HealthTronics, Inc.

HealthTronics provides healthcare services primarily to the Urology community and manufactures and distributes medical devices. The Company also manufactures specialty vehicles used for the transport of high-technology medical devices and broadcast & communications equipment. For more information, visit www.healthtronics.com.

LISA laser has utilized unique technology to develop RevoLix, a Continuous Wave 2micron laser which is the first innovation in surgical lasers in almost ten years. RevoLix is the only CW 2micron laser in the world that has been FDA approved for medical procedures in the U.S. market and it overcomes many of the problems associated with other lasers when being used for vaporization and incision of soft tissue.

The RevoLix is FDA approved for the treatment of Benign Prostatic Hyperplasia (BPH) and eliminates the problems associated with the KTP and Holmium laser. Visualization is vastly improved because of the lack of the “bubble effect”. Lower laser powers are needed to produce a smoother vaporization with much less trauma to surrounding structures. It has been used for treating BPH for almost three years in Europe extremely successfully.

LISA Laser USA, Inc., is the exclusive distributor for LISA Laser products in the United States.

LISA Laser USA - dedicated to supplying the best technology for medicine.